Home » Topics » Science » New compound

New compound
RSS

EGFR-TKI TAS-3351 overcomes T790M and C797S mutations tied to NSCLC treatment resistance

April 25, 2022

AUR-103 in combination with azacytidine and bortezomib for myeloma and leukemia treatment

April 20, 2022

Plexium compound shows the promise of BRD4 degradation for prostate cancer

April 20, 2022

TLR2/6 agonist AXA-042 shows antitumor activity and tolerability in vivo

April 20, 2022

IKZF2 degrader PLX-4107 shows promise as cancer immunotherapeutic

April 19, 2022

FGFR2-selective inhibitor CGT-0292 shows promise for treating hyperphosphatemia

April 13, 2022

Peptidomimetic TMPRSS2 inhibitor shows prophylactic and therapeutic activity against SARS-CoV-2 VOCs

April 7, 2022

Researchers present [11C]JMJ-81 as a new PET tracer for brain PDE4D quantification

April 4, 2022

AZD-9574: a selective PARP1 inhibitor suitable for cancer treatment

April 4, 2022

AC-0027136 improves memory impairment and mitochondrial function

March 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...